Search Results - "Sacchelli, L."

Early kinetics of innate and adaptive immune responses during hepatitis B virus infection by Fisicaro, P, Valdatta, C, Boni, C, Massari, M, Mori, C, Zerbini, A, Orlandini, A, Sacchelli, L, Missale, G, Ferrari, C

“…Innate immunity appears to be silent in acutely hepatitis B virus (HBV)-infected chimpanzees, as shown by microarray analysis of intrahepatic gene expression…”
Get more information

The burden of psoriasis on patient's caregivers by Bardazzi, F., Clarizio, G., Marani, A., Tengattini, V., Sacchelli, L.

Get full text

Itchy plaques on trunk and feet in a patient with dark skin: a case of Dystrophic Calcinosis Cutis superimposed on Lichen Simplex Chronicus by Bardazzi, F., Misciali, C., Sacchelli, L., Evangelista, V.

Get full text

Combination therapy of apremilast and secukinumab in patients with moderate‐to‐severe, recalcitrant plaque psoriasis by Sacchelli, L., Patrizi, A., Loi, C., Bardazzi, F.

Get full text

Clinical course and therapeutic management of juvenile pemphigus vulgaris: A retrospective analysis from an Italian referral centre by Filippi, F, Loi, C, Chessa, M A, Sacchelli, L, Gabusi, A, Gissi, D B, Bardazzi, F

Get full text

Sexually transmitted infections during the COVID‐19 outbreak: comparison of patients referring to the service of sexually transmitted diseases during the sanitary emergency with those referring during the common practice by Sacchelli, L., Viviani, F., Orioni, G., Rucci, P., Rosa, S., Lanzoni, A., Patrizi, A., Gaspari, V.

Get full text

Successful treatment of refractory Hailey–Hailey disease with apremilast by Di Altobrando, A., Sacchelli, L., Patrizi, A., Bardazzi, F.

Get full text

Reply to “Dermatoses caused by face mask wearing during the COVID‐19 pandemic” by Bardazzi, F., Sacchelli, L., Loi, C., Filippi, F., Guglielmo, A.

Get full text

PsoBioVax: A multicentric Italian case–control study of the immunological response to anti‐SARS‐CoV‐2 vaccine among psoriatic patients under biological therapy by Sacchelli, L., Filippi, F., Balato, A., Balestri, R., Bellinato, F., Bernardini, N., Bianchi, L., Burlando, M., Campanati, A., Chessa, M. A., Corazza, M., Di Cesare, A., Di Lernia, V., Diotallevi, F., Esposito, M., Fargnoli, M. C., Gisondi, P., Giunta, A., Hansel, K., Magnano, M., Megna, M., Odorici, G., Prignano, F., Potenza, C., Rech, G., Rovesti, M., Ruggiero, A., Satolli, F., Stingeni, L., Gibertoni, D., Bardazzi, F.

Get full text

Idiopathic granulomatous vulvitis and subsequent oral granulomatosis: a diagnostic and therapeutic challenge by Sacchelli, L., Tengattini, V., Baraldi, C., Filippi, F., Loi, C., Ferrara, F., Patrizi, A., Bardazzi, F.

Get full text

Cascade Reactions Assisted by Microwave Irradiation: Ultrafast Construction of 2‑Quinolinone-Fused γ‑Lactones from N‑(o‑Ethynylaryl)acrylamides and Formamide by Sacchelli, Bruce A. L, Rocha, Bianca C, Andrade, Leandro H

“…An ultrafast (10 s) methodology to construct novel highly functionalized 2-quinolinones from N-(o-ethynylaryl)­acrylamides (1,7-enynes) is described for the…”
Get full text

[94] PERSISTENT IMPAIRMENT OF HCV-SPECIFIC CDS CELL RESPONSE IN HCV-RNA NEGATIVE PATIENTS AFTER SUCCESSFUL PEG-INTERFERON/RIBAVIRIN TREATMENT by Missale, G, Pilli, M, Penna, A, Zerbini, A, Sacchelli, L, Mori, C, Mezzadri, S, Ferrari, C

Get full text

5 BETTER SUSTAINED CONTROL OF CHRONIC GENOTYPE 1 HCV INFECTIONS WITH PEG-IFN ALFA-2A THAN WITH PEG-IFN ALFA-2B TREATMENT: RESULTS OF DAILY CLINICAL PRACTICE by Orlandini, A, Borghi, V, Sacchelli, L, Valli, A, Bertoni, R, Verucchi, G, Piergentili, B, Testa, L, Andreone, P, Massari, M, Carradori, S.D, Ghinelli, F, Sacchini, D, Abbati, G, Pietrangelo, A, Vandelli, C, Ferrari, C

Get full text

Molecular Construction Using Formamide as a C1 Feedstock by Sacchelli, Bruce A. L., Rocha, Bianca C., Fantinel, Mariane, Andrade, Leandro H.

“…Formamide (HCONH2), a well‐known organic compound in chemistry and biology, can be employed for molecular construction. The chemistry of formamide, which…”
Get full text

032 Immunogenicity of biologic therapies in psoriasis by Di Caprio, R., Sacchelli, L., Di Spigna, G., Ricciardone, M., Bardazzi, F., Ladogana, P., Scala, E., Covelli, B., Balato, A., Postiglione, L.

Get full text

Prediction of significant fibrosis in chronic hepatitis C patients by artificial neural network analysis of clinical factors by Piscaglia, F, Cucchetti, A, Orlandini, A, Sagrini, E, Gianstefani, A, Crespi, C, Pelosi, G, Valli, M.A, Sacchelli, L, Ferrari, C, Bolondi, L

Get full text

240 Serum polyclonal free light chains: possible markers of immune activation in psoriasis by Di Caprio, R., Sacchelli, L., Di Spigna, G., Ricciardone, M., Bardazzi, F., Ladogana, P., Scala, E., Covelli, B., Balato, A., Postiglione, L.

Get full text

Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study by Talamonti, Marina, Galluzzo, Marco, Chiricozzi, Andrea, Quaglino, Pietro, Fabbrocini, Gabriella, Gisondi, Paolo, Marzano, Angelo Valerio, Potenza, Concetta, Conti, Andrea, Parodi, Aurora, Piaserico, Stefano, Bardazzi, Federico, Argenziano, Giuseppe, Rongioletti, Franco, Stingeni, Luca, Micali, Giuseppe, Loconsole, Francesco, Rossi, Maria Teresa, Bongiorno, Maria Rita, Feliciani, Claudio, Rubegni, Pietro, Amerio, Paolo, Fargnoli, Maria Concetta, Pigatto, Paolo, Savoia, Paola, Nisticò, Steven Paul, Giustini, Sandra, Carugno, Andrea, Cannavo', Serafinella Patrizia, Rech, Giulia, Prignano, Francesca, Offidani, Annamaria, Lombardo, Maurizio, Zalaudek, Iris, Bianchi, Luca, Peris, Ketty, Balestri R, Bernardini N, Belloni Fortini A, Burlando M, Caldarola G, Campione E, Cattaneo A, Dapavo P, Dastoli S, De Simone C, Di Nuzzo S, Diotallevi F, Fierro MT, Franchi C, Esposito M, Foti C, Gambini DM, Gambardella A, Girolomoni G, Giunta A, Guarneri C, Gualdi G, Hansel K, Megna M, Mugheddu C, Musumeci ML, Patrizi A, Pellacani G, Richetta AG, Rosi E, Sacchelli L, Tiberio R, Tilotta G, Trovato E, Venturini M, Vezzoni R

“…: The susceptibility of patients with chronic plaque psoriasis and the risks or benefits related to the use of biological therapies for COVID-19 are unknown…”
Get more information

Brodalumab for the treatment of moderate‐to‐severe plaque‐type psoriasis: a real‐life, retrospective 24‐week experience by Fargnoli, M.C., Esposito, M., Dapavo, P., Parodi, A., Rossi, M., Tiberio, R., Dastoli, S., Offidani, A.M., Argenziano, G., Gisondi, P., Lo Schiavo, A., Loconsole, F., Pella, P., Bardazzi, F., Cusano, F., Gattoni, M., Nacca, M., Cannavò, S.P., Pellegrini, C., Costanzo, A., Pertusi, G., Stroppiana, E., Gambardella, A., Romano, F., Sassetti, C., Carpentieri, A., Bellinato, F., Burlando, M., Graziola, F., Sacchelli, L., Campanati, A., Ronza, G.

“…Background Brodalumab was efficacious and safe in moderate‐to‐severe plaque‐type psoriasis in the AMAGINE trials; published reports under real‐life conditions…”
Get full text

The potential role of serum polyclonal free light chains as markers of immune activation in psoriatic patients by Di Caprio, Roberta, Sacchelli, Lidia, Di Spigna, Gaetano, Ricciardone, Margherita, Bardazzi, Federico, Ladogana, Paolo, Scala, Emanuele, Fabbrocini, Gabriella, Covelli, Bianca, Balato, Anna, Postiglione, Loredana

“…Background Polyclonal free light chains (FLCs) of immunoglobulins include κ and λ chains and represent a sensitive marker of activation and/or dysfunction of…”
Get full text